The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics, and Proscia ®, a global leader in AI-enabled pathology ...